Rapport therapeutics to participate in upcoming investor conferences

Boston and san diego, april 22, 2025 (globe newswire) -- rapport therapeutics, inc. (nasdaq: rapp) (“rapport” or the “company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for patients with neurological or psychiatric disorders, today announced that management plans to participate in three upcoming investor conferences. jones trading virtual cns symposium - fireside chat on tuesday, april 29, 2025, from 11:00-11:25am et.
RAPP Ratings Summary
RAPP Quant Ranking